Coumadin and Optic neuropathy - a phase IV clinical study of FDA data

Summary:

Optic neuropathy is reported as a side effect among people who take Coumadin (warfarin sodium), especially for people who are male, 60+ old, also take Protonix, and have Breast cancer.

The phase IV clinical study analyzes which people have Optic neuropathy when taking Coumadin. It is created by eHealthMe based on reports of 128,882 people who have side effects when taking Coumadin from the FDA, and is updated regularly.

What is Coumadin?

Coumadin has active ingredients of warfarin sodium. It is often used in blood clots. eHealthMe is studying from 133,228 Coumadin users. Check the latest studies of Coumadin.

What is Optic neuropathy?

Optic neuropathy (optic nerve damage) is found to be associated with 256 drugs and 452 conditions by eHealthMe. Check the latest studies of Optic neuropathy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

128,882 people reported to have side effects when taking Coumadin.
Among them, 27 people (0.02%) have Optic neuropathy.

Among these 27 people:

What is the gender of people who have Optic neuropathy when taking Coumadin? *

female: 44.44 %
male: 55.56 %

What is the age of people who have Optic neuropathy when taking Coumadin? *

What are other drugs people take besides Coumadin? *

What are other side effects people have besides Optic neuropathy? *

Vision Blurred: 11 people, 40.74%
Dyspnea (difficult or laboured breathing): 8 people, 29.63%
Fatigue (feeling of tiredness): 8 people, 29.63%
Joint Pain: 8 people, 29.63%
Anaemia (lack of blood): 8 people, 29.63%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 8 people, 29.63%
Musculoskeletal Discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves): 8 people, 29.63%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 8 people, 29.63%
Headache (pain in head): 8 people, 29.63%
Hair Loss: 8 people, 29.63%

What are the existing conditions these people have? *

Breast Cancer: 7 people, 25.93%
Lung Cancer - Non-Small Cell (lung cancer): 4 people, 14.81%
Diabetes: 4 people, 14.81%
Arrhythmias (irregular heartbeat): 3 people, 11.11%
Asthma: 2 people, 7.41%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 3.70%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 3.70%
Brain Neoplasm (tumour of brain): 1 person, 3.70%
Depression: 1 person, 3.70%
Prostatic Disorder: 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Coumadin and have Optic neuropathy?

- Check whether Optic neuropathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Coumadin:

Coumadin (133,228 reports)

Browse all side effects of Coumadin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Optic neuropathy:

Optic neuropathy (256 drugs)

Browse all the conditions that are associated with Optic neuropathy:

Optic neuropathy (452 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on warfarin sodium (the active ingredients of Coumadin) and Coumadin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.